<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>1698</number>
    <updateDate>2023-01-13T04:50:01Z</updateDate>
    <updateDateIncludingText>2023-01-13T04:50:01Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2005-09-14</introducedDate>
    <congress>109</congress>
    <committees>
      <item>
        <systemCode>ssfi00</systemCode>
        <name>Finance Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2005-09-14T19:44:37Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Vaccines for the New Millennium Act of 2005</title>
        <congress>109</congress>
        <number>3781</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2005-10-17</actionDate>
          <text>Referred to the Subcommittee on Domestic and International Monetary Policy, Trade, and Technology.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2005-09-14</actionDate>
        <committees>
          <item>
            <systemCode>ssfi00</systemCode>
            <name>Finance Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S10040-10043)</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2005-09-14</actionDate>
        <text>Sponsor introductory remarks on measure. (CR S10039-10040)</text>
        <type>IntroReferral</type>
        <actionCode>B00100</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2005-09-14</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>K000148</bioguideId>
        <fullName>Sen. Kerry, John F. [D-MA]</fullName>
        <firstName>JOHN</firstName>
        <lastName>KERRY</lastName>
        <party>D</party>
        <state>MA</state>
        <middleName>FORBES</middleName>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>L000504</bioguideId>
        <fullName>Sen. Lugar, Richard G. [R-IN]</fullName>
        <firstName>RICHARD</firstName>
        <lastName>LUGAR</lastName>
        <party>R</party>
        <state>IN</state>
        <middleName>GREEN</middleName>
        <sponsorshipDate>2005-09-14</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B000444</bioguideId>
        <fullName>Sen. Biden, Joseph R., Jr. [D-DE]</fullName>
        <firstName>JOSEPH</firstName>
        <lastName>BIDEN</lastName>
        <party>D</party>
        <state>DE</state>
        <middleName>ROBINETTE</middleName>
        <sponsorshipDate>2005-10-17</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000563</bioguideId>
        <fullName>Sen. Durbin, Richard J. [D-IL]</fullName>
        <firstName>Richard</firstName>
        <lastName>Durbin</lastName>
        <party>D</party>
        <state>IL</state>
        <middleName>J.</middleName>
        <sponsorshipDate>2005-12-12</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S001163</bioguideId>
        <fullName>Sen. Salazar, Ken [D-CO]</fullName>
        <firstName>Ken</firstName>
        <lastName>Salazar</lastName>
        <party>D</party>
        <state>CO</state>
        <sponsorshipDate>2006-02-02</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M001111</bioguideId>
        <fullName>Sen. Murray, Patty [D-WA]</fullName>
        <firstName>Patty</firstName>
        <lastName>Murray</lastName>
        <party>D</party>
        <state>WA</state>
        <sponsorshipDate>2006-05-09</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C000127</bioguideId>
        <fullName>Sen. Cantwell, Maria [D-WA]</fullName>
        <firstName>Maria</firstName>
        <lastName>Cantwell</lastName>
        <party>D</party>
        <state>WA</state>
        <sponsorshipDate>2006-05-12</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>AIDS (Disease)</name>
        </item>
        <item>
          <name>Child health</name>
        </item>
        <item>
          <name>Clinical trials</name>
        </item>
        <item>
          <name>Commerce</name>
        </item>
        <item>
          <name>Communicable diseases</name>
        </item>
        <item>
          <name>Competition</name>
        </item>
        <item>
          <name>Congress</name>
        </item>
        <item>
          <name>Congressional reporting requirements</name>
        </item>
        <item>
          <name>Contracts</name>
        </item>
        <item>
          <name>Corporation taxes</name>
        </item>
        <item>
          <name>Developing countries</name>
        </item>
        <item>
          <name>Development credit institutions</name>
        </item>
        <item>
          <name>Dispute settlement</name>
        </item>
        <item>
          <name>Drug approvals</name>
        </item>
        <item>
          <name>Drug industry</name>
        </item>
        <item>
          <name>Drugs</name>
        </item>
        <item>
          <name>Economics and Public Finance</name>
        </item>
        <item>
          <name>Families</name>
        </item>
        <item>
          <name>Foreign Trade and International Finance</name>
        </item>
        <item>
          <name>Gifts</name>
        </item>
        <item>
          <name>Government Operations and Politics</name>
        </item>
        <item>
          <name>Government contractors</name>
        </item>
        <item>
          <name>Government procurement</name>
        </item>
        <item>
          <name>Government trust funds</name>
        </item>
        <item>
          <name>Governmental investigations</name>
        </item>
        <item>
          <name>Human immunodeficiency viruses</name>
        </item>
        <item>
          <name>Income tax</name>
        </item>
        <item>
          <name>Intellectual property</name>
        </item>
        <item>
          <name>International Affairs</name>
        </item>
        <item>
          <name>International agencies</name>
        </item>
        <item>
          <name>International cooperation in science</name>
        </item>
        <item>
          <name>Law</name>
        </item>
        <item>
          <name>Liability (Law)</name>
        </item>
        <item>
          <name>Malaria</name>
        </item>
        <item>
          <name>Medical malpractice</name>
        </item>
        <item>
          <name>Medical technology</name>
        </item>
        <item>
          <name>Negotiations</name>
        </item>
        <item>
          <name>Nongovernmental organizations</name>
        </item>
        <item>
          <name>Nonprofit organizations</name>
        </item>
        <item>
          <name>Patents</name>
        </item>
        <item>
          <name>Pharmaceutical research</name>
        </item>
        <item>
          <name>Preventive medicine</name>
        </item>
        <item>
          <name>Prices</name>
        </item>
        <item>
          <name>Public-private partnerships</name>
        </item>
        <item>
          <name>Research and development</name>
        </item>
        <item>
          <name>Research and development tax credit</name>
        </item>
        <item>
          <name>Research grants</name>
        </item>
        <item>
          <name>Science, Technology, Communications</name>
        </item>
        <item>
          <name>Small business</name>
        </item>
        <item>
          <name>Social Welfare</name>
        </item>
        <item>
          <name>Tax credits</name>
        </item>
        <item>
          <name>Tax refunds</name>
        </item>
        <item>
          <name>Taxation</name>
        </item>
        <item>
          <name>Technology transfer</name>
        </item>
        <item>
          <name>Treaties</name>
        </item>
        <item>
          <name>Tuberculosis</name>
        </item>
        <item>
          <name>United Nations</name>
        </item>
        <item>
          <name>Vaccination</name>
        </item>
        <item>
          <name>Vaccines</name>
        </item>
        <item>
          <name>World health</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2005-09-14</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2005-11-08T20:07:31Z</updateDate>
        <text><![CDATA[ <p>Vaccines for the New Millennium Act of 2005 - Directs the President to establish a strategy to accelerate efforts to develop vaccines and microbicides for neglected diseases such as HIV/AIDS, malaria, and tuberculosis, which shall: (1) expand public-private partnerships; (2) create economic incentives for such vaccines' research, development, and manufacturing; (3) include the negotiation of advanced market commitments; (4) address related intellectual property and regulatory approval issues; (5) maximize U.S. capabilities to support clinical trials in developing countries; (6) expand the purchase and delivery of existing vaccines; and (7) address the challenges of advance delivery of vaccines in developing countries. </p> <p>Directs the Secretary of the Treasury to: (1) enter into negotiations with the World Bank, the International Development Association, Global Alliance for Vaccines and Immunizations, and other interested parties to establish advanced market commitments to purchase such vaccines and microbicides; and (2) establish in the Treasury the Lifesaving Vaccine Purchase Fund.</p> <p>Amends the Internal Revenue Code to establish business credits for: (1) vaccine research related to HIV/AIDS, malaria, tuberculosis, or certain infectious diseases afflicting developing countries; and (2) certain sales of lifesaving vaccines to nonprofit organizations, or to foreign governments or instrumentalities for distribution in developing countries.</p> <p>Amends the Small Business Act to: (1) direct the Small Business Administration (SBA) to establish a four-year pilot program to encourage the development of such vaccines and microbicides, including program outreach activities; and (2) provide Small Business Innovation Research Program (SBIR) and Small Business Technology Transfer Program (STTR) funding for such vaccines and microbicides.</p> </p>]]></text>
      </summary>
    </summaries>
    <title>Vaccines for the New Millennium Act of 2005</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Vaccines for the New Millennium Act of 2005</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to accelerate efforts to develop vaccines for diseases primarily affecting developing countries, and for other purposes.</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Vaccines for the New Millennium Act of 2005</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2005-09-14T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-109s1698is/xml/BILLS-109s1698is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2005-09-14</actionDate>
      <text>Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S10040-10043)</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
